Brief: PaxMedica Responds To Emergency Request For IV Suramin And Commits To Provide Immediate Access To PAX-101
23/04/2024 13:53
April 23 (Reuters) - PaxMedica Inc PXMD.O :
* PAXMEDICA RESPONDS TO EMERGENCY REQUEST FOR IV SURAMIN AND
COMMITS TO PROVIDE IMMEDIATE ACCESS TO PAX-101
* PAXMEDICA INC - EXPECTS TO TAKE IMMEDIATE ACTION IN
RESPONSE TO
AN URGENT REQUEST FOR IV SURAMIN FROM MOH OF MALAWI
Source text for Eikon: ID:nGNE6wRMrW
Further company coverage: PXMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kuvatris Therapeutics
See all newsBrief: PaxMedica Responds To Emergency Request For IV Suramin And Commits To Provide Immediate Access To PAX-101
PaxMedica rises on Malawi's request for access to sleeping sickness drug
Brief: Paxmedica Receives Emergency Request For Iv Suramin From African Health Ministry For Use In Treating Fatal Sleeping Sickness
Brief: PaxMedica Achieves Key Milestone In The Development Of PAX-101 And Provides Update On Potential NDA Submission
Brief: Paxmedica Announces Pricing Of $7.0 Million Public Offering